Assessing Novavax (NVAX) Valuation After Pfizer Matrix M Licensing Deal [Yahoo! Finance]
Novavax, Inc. (NVAX)
Last novavax, inc. earnings: 3/11 04:17 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.novavax.com/investor-relations
Company Research
Source: Yahoo! Finance
Novavax (NVAX) has become a focus for investors after signing a license agreement that allows Pfizer to use its Matrix-M adjuvant in up to two disease areas, with upfront, milestone, and royalty payments included. See our latest analysis for Novavax. The Matrix M agreement and Novavax's upcoming appearance at the J.P. Morgan Healthcare Conference come after a 23.1% 1 month share price return to US$8.20. However, the 1 year total shareholder return of a 6.9% decline and the 5 year total shareholder return of a 93.6% decline show that recent momentum is emerging from a much weaker long term record. If you are looking beyond a single vaccine name, this could be a useful moment to see how other healthcare stocks compare on fundamentals and recent share price trends. With the stock trading at US$8.20, sitting at a large intrinsic discount and a sizeable gap to analyst targets, the question is whether Novavax is being undervalued or if the market is already pricing in future growth
Show less
Read more
Impact Snapshot
Event Time:
NVAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVAX alerts
High impacting Novavax, Inc. news events
Weekly update
A roundup of the hottest topics
NVAX
News
- Pfizer Taps Novavax Matrix-M To Refresh Vaccine Growth Story [Yahoo! Finance]Yahoo! Finance
- Pfizer Reshapes Portfolio With Obesity Bet, Vaccine Deal And Pricing Shift [Yahoo! Finance]Yahoo! Finance
- Pfizer Reshapes Portfolio With New Partnerships Oncology Push And Pricing Shifts [Yahoo! Finance]Yahoo! Finance
- BofA Notes Positive Interest in Novavax, Inc. (NVAX) Technology Despite Timing Concerns for Licensed Assets [Yahoo! Finance]Yahoo! Finance
- Moderna Vs. Novavax: 2 Pandemic Vaccine Pioneers - Which Offers Better Value Today? [Seeking Alpha]Seeking Alpha
NVAX
Earnings
- 11/6/25 - Miss
NVAX
Sec Filings
- 1/26/26 - Form 4
- 1/20/26 - Form 8-K
- 1/12/26 - Form 8-K
- NVAX's page on the SEC website